Alanine transferase levels (ALT) and triglyceride-glucose index are risk factors for type 2 diabetes mellitus in obese patients

被引:3
作者
Folli, Franco [1 ]
Pontiroli, Antonio E. [1 ]
Zakaria, Ahmed S. [2 ]
Centofanti, Lucia [1 ]
Tagliabue, Elena [3 ]
La Sala, Lucia [3 ]
机构
[1] Univ Milan, Dipartimento Sci Salute, Milan, Italy
[2] Osped San Paolo, Milan, Italy
[3] IRCCS Multimed, Lab Cardiovasc & Dysmetabol Dis, Milan, Italy
关键词
Liver; Type; 2; diabetes; Triglyceride-glucose index; Metabolic syndrome; METABOLIC SYNDROME; LIVER-ENZYMES; WEIGHT-LOSS; INSULIN;
D O I
10.1007/s00592-023-02209-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AimsThe role of liver steatosis and increased liver enzymes (ALT) in increasing incident type 2 diabetes mellitus (T2DM) is debated, because of their differential effects on different ethnicities and populations. The aim of this study was to evaluate the role of elevated ALT in the development of T2DM in non-diabetic obese subjects receiving routine medical treatment.MethodsA total of 1005 subjects [296 men and 709 women, aged 45.7 +/- 13.12 years, body mass index (BMI) 39.5 +/- 4.86 kg/m2] were followed for a mean period of 14.3 +/- 4.44 years. Subjects were evaluated for several metabolic variables, including the triglyceride-glucose index and the presence of metabolic syndrome (IDF 2005 definition), and were subdivided into ALT quartiles.ResultsT2DM developed in 136 subjects, and the difference was significant between the first and the fourth ALT quartile (p = 0.048). Both at univariate analysis and at stepwise regression, ALT quartiles were associated with incident T2DM. Traditional risk factors for T2DM coexisted, with a somehow greater predictive value, such as triglyceride-glucose index, age, arterial hypertension, LDL-cholesterol, and metabolic syndrome.ConclusionsThese data suggest an association between elevated ALT levels and the risk of incident T2DM in obesity.
引用
收藏
页码:435 / 440
页数:6
相关论文
共 24 条
  • [1] agenziafarmaco, RAPPORTO OSMED 2011
  • [2] Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients
    Alizargar, Javad
    Bai, Chyi-Huey
    Hsieh, Nan-Chen
    Wu, Shu-Fang Vivienne
    [J]. CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
  • [3] The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions
    Athyros, VG
    Ganotakis, ES
    Elisaf, M
    Mikhailidis, DP
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (08) : 1157 - 1159
  • [4] Transitioning from having no metabolic abnormality nor obesity to metabolic impairment in a cohort of apparently healthy adults
    Ben-Assayag, Hadas
    Brzezinski, Rafael Y.
    Berliner, Shlomo
    Zeltser, David
    Shapira, Itzhak
    Rogowski, Ori
    Toker, Sharon
    Eldor, Roy
    Shenhar-Tsarfaty, Shani
    [J]. CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [5] Statins and the Risk of Diabetes: Evidence From a Large Population-Based Cohort Study
    Corrao, Giovanni
    Ibrahim, Buthaina
    Nicotra, Federica
    Soranna, Davide
    Merlino, Luca
    Catapano, Alberico L.
    Tragni, Elena
    Casula, Manuela
    Grassi, Guido
    Mancia, Giuseppe
    [J]. DIABETES CARE, 2014, 37 (08) : 2225 - 2232
  • [6] A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
    Eslam, Mohammed
    Newsome, Philip N.
    Sarin, Shiv K.
    Anstee, Quentin M.
    Targher, Giovanni
    Romero-Gomez, Manuel
    Zelber-Sagi, Shira
    Wong, Vincent Wai-Sun
    Dufour, Jean-Francois
    Schattenberg, Joern M.
    Kawaguchi, Takumi
    Arrese, Marco
    Valenti, Luca
    Shiha, Gamal
    Tiribelli, Claudio
    Yki-Jarvinen, Hannele
    Fan, Jian-Gao
    Gronbaek, Henning
    Yilmaz, Yusuf
    Cortez-Pinto, Helena
    Oliveira, Claudia P.
    Bedossa, Pierre
    Adams, Leon A.
    Zheng, Ming-Hua
    Fouad, Yasser
    Chan, Wah-Kheong
    Mendez-Sanchez, Nahum
    Ahn, Sang Hoon
    Castera, Laurent
    Bugianesi, Elisabetta
    Ratziu, Vlad
    George, Jacob
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 (01) : 202 - 209
  • [7] Liver steatosis (LS) evaluated through chemical-shift magnetic resonance imaging liver enzymes in morbid obesity; effect of weight loss obtained with intragastric balloon gastric banding
    Folini, Laura
    Veronelli, Annamaria
    Benetti, Alberto
    Pozzato, Carlo
    Cappelletti, Marco
    Masci, Enzo
    Micheletto, Giancarlo
    Pontiroli, Antonio E.
    [J]. ACTA DIABETOLOGICA, 2014, 51 (03) : 361 - 368
  • [8] Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels - A potential role for serine phosphorylation in insulin/angiotensin II crosstalk
    Folli, F
    Kahn, CR
    Hansen, H
    Bouchie, JL
    Feener, EP
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (09) : 2158 - 2169
  • [9] Bariatric surgery in obesity: Changes of glucose and lipid metabolism correlate with changes of fat mass
    Frige, F.
    Laneri, M.
    Veronelli, A.
    Folli, F.
    Paganelli, M.
    Vedani, P.
    Marchi, M.
    Noe, D.
    Ventura, P.
    Opocher, E.
    Pontiroli, A. E.
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2009, 19 (03) : 198 - 204
  • [10] Elevated Concentrations of Liver Enzymes and Ferritin Identify a New Phenotype of Insulin Resistance: Effect of Weight Loss After Gastric Banding
    Gastaldelli, Amalia
    Perego, Lucia
    Paganelli, Michele
    Sesti, Giorgio
    Hribal, Marta
    Chavez, Alberto O.
    DeFronzo, Ralph A.
    Pontiroli, Antonio
    Folli, Franco
    [J]. OBESITY SURGERY, 2009, 19 (01) : 80 - 86